Transaction in Own Shares

Summary by AI BETAClose X

Melrose Industries PLC has announced the purchase of 261,000 ordinary shares between May 26th and May 29th, 2026, through Merrill Lynch International. The volume-weighted average purchase price ranged from 475.1349p to 485.6010p, with the lowest price per share at 463.4000p and the highest at 492.2000p. These acquired shares will be held in treasury, bringing the total treasury shares to 65,051,726 and leaving 1,246,423,595 ordinary shares in issue.

Disclaimer*

Melrose Industries PLC
01 June 2026
 







1ˢᵗ June 2026




Melrose Industries PLC

("Melrose" or the "Company")

Transaction in Own Shares

 






The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 26ᵗʰ May 2026 to 29ᵗʰ May 2026.







Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (pence)

Highest price per share (p)

26 May 2026

XLON

485.6010

63,000

479.2000

492.2000

27 May 2026

XLON

477.4086

63,000

463.4000

484.5000

28 May 2026

XLON

475.4604

68,000

468.7000

482.2000

29 May 2026

XLON

475.1349

67,000

471.0000

480.7000



















The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company has 65,051,726 ordinary shares in treasury and has 1,246,423,595 ordinary shares in issue (excluding treasury shares).













Individual Transactions

 



In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/3231G_1-2026-5-29.pdf

 









For further information please contact:




Warren Fernandez                        Company Secretary



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings